Viviany Taqueti, MD, MPH is a cardiologist, clinical investigator and Director of the Cardiac Stress Laboratory at Brigham and Women’s Hospital and faculty at Harvard Medical School. She is an expert in cardiometabolic, ischemic and inflammatory heart disease with a focus on applying multimodality imaging technology to quantify coronary blood flow, atherosclerotic plaque, microvascular dysfunction and body composition for refining cardiovascular risk. Over the last decade, she has pioneered the role of residual inflammation and coronary microvascular dysfunction on adverse cardiovascular outcomes, including heart failure with preserved ejection fraction in patients with cardiometabolic disease. Her research has facilitated clinical translation of advanced imaging biomarkers in evaluating women’s heart disease and developing evidence-based national guidelines for diagnosis of coronary microvascular dysfunction in patients with chest pain.

Dr. Taqueti is a physician-scientist, collaborative leader and strategic thinker with a global perspective. She graduated summa cum laude from Harvard University in biochemical sciences, magna cum laude from Harvard Medical School through the Harvard-MIT Division of Health Sciences and Technology, and completed internal medicine and cardiovascular medicine and imaging training at Massachusetts General Hospital and Brigham and Women’s Hospital. She has a Master from the Harvard School of Public Health and executive training in healthcare leadership from Harvard Business School. She is board certified in Internal Medicine, Cardiovascular Disease, Echocardiography and Nuclear Cardiology. She is an elected member of the Faculty Council at Harvard Medical School, an associate member at the Broad Institute of MIT and Harvard, and an advisor at Broadview Ventures, a mission-driven fund for impact investing in cardiovascular disease. A former editorial assistant at The New England Journal of Medicine, she is immediate past-Chair of the Scientific Publications Committee of the American College of Cardiology where she oversaw expansion to the 10-member JACC Journal portfolio and Chairs the Digital Transformation Committee with a $19 million strategic project budget. She is on the Editorial Board of the European Heart Journal, Board of Directors of the American Society of Nuclear Cardiology, and a member of writing committees for the 2023 American Heart Association/American College of Cardiology guideline for the Diagnosis and Management of Patients with Chronic Coronary Disease and the 2023 National Academies of Sciences, Engineering and Medicine report on Advances in the Diagnosis and Evaluation of Disabling Physical Health Conditions. Her work is supported by federal and foundation grants and has been published in top academic journals including The New England Journal of Medicine, Circulation, the Journal of the American College of Cardiology and European Heart Journal. She is an experienced member of Data Safety Monitoring Boards and Clinical Endpoint Adjudication Committees for major multicenter trials, and a frequent invited national and international speaker. She was born in Vitoria, Brazil, and spent her early years in Brazil’s northern Amazon region and Connecticut.

A listing of her published academic work can be viewed here: https://pubmed.ncbi.nlm.nih.gov/?term=taqueti+v&sort=date